Literature DB >> 17116377

ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics.

Guosen He1, Lwin Lwin Ma, Jie Pan, Subbu Venkatraman.   

Abstract

We synthesized two types of triblock copolymers containing PEG and PLA as controlled release carriers of hydrophobic drugs: these are the ABA type (PLA-PEG-PLA) and the BAB type (PEG-PLA-PEG). These polymers are amphiphilic and can form nanomicelles (40-200nm) in aqueous medium. On the surface of PLA-PEG-PLA (ABA) type nanomicelles, the PEG content was enhanced somewhat over the bulk amount; whereas in the PEG-PLA-PEG (BAB type), surface segregation was much higher. The copolymers tested can entrap 35% of paclitaxel by weight on the average. In general, the diffusion-controlled release of paclitaxel is slower for the BAB polymers; furthermore, the actual release rates are influenced by the PLLA lengths in the BAB copolymers. Surface PEG contents influence the "stealth" characteristics of the nanomicelles. Compared with PLA particles, all nanomicellar particles tested, of both BAB and ABA types, showed a four-fold reduction in monocyte cell uptake, with the BAB type copolymer exhibiting a lesser uptake.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116377     DOI: 10.1016/j.ijpharm.2006.10.020

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.

Authors:  Feihu Wang; Michael Porter; Alexandros Konstantopoulos; Pengcheng Zhang; Honggang Cui
Journal:  J Control Release       Date:  2017-09-25       Impact factor: 9.776

Review 2.  Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery.

Authors:  Mirnal A Chaudhary; Lian-Wang Guo; Xudong Shi; Guojun Chen; Shaoqin Gong; Bo Liu; K Craig Kent
Journal:  J Control Release       Date:  2016-05-12       Impact factor: 9.776

3.  Quantitative analysis of hemoglobin content in polymeric nanoparticles as blood substitutes using Fourier transform infrared spectroscopy.

Authors:  Xiaoqian Shan; Ligen Chen; Yuan Yuan; Changsheng Liu; Xiaolan Zhang; Yan Sheng; Feng Xu
Journal:  J Mater Sci Mater Med       Date:  2010-01       Impact factor: 3.896

4.  Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents.

Authors:  Hanping Wu; Eric C Abenojar; Reshani Perera; Al Christopher De Leon; Tianzhi An; Agata A Exner
Journal:  Ultrasound Med Biol       Date:  2019-06-24       Impact factor: 2.998

5.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.

Authors:  Yen Cu; W Mark Saltzman
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

Review 6.  Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval.

Authors:  Duhyeong Hwang; Jacob D Ramsey; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2020-09-24       Impact factor: 15.470

7.  Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.

Authors:  Hanping Wu; Nicolas G Rognin; Tianyi M Krupka; Luis Solorio; Hiroki Yoshiara; Gilles Guenette; Christopher Sanders; Naohisa Kamiyama; Agata A Exner
Journal:  Ultrasound Med Biol       Date:  2013-08-09       Impact factor: 2.998

8.  Paclitaxel Nano-Delivery Systems: A Comprehensive Review.

Authors:  Ping Ma; Russell J Mumper
Journal:  J Nanomed Nanotechnol       Date:  2013-02-18

9.  Co-delivery of Sildenafil (Viagra(®)) and Crizotinib for synergistic and improved anti-tumoral therapy.

Authors:  João G Marques; Vítor M Gaspar; David Markl; Elisabete C Costa; Eugénia Gallardo; Ilídio J Correia
Journal:  Pharm Res       Date:  2014-03-13       Impact factor: 4.200

Review 10.  Nanomedicine for treating spinal cord injury.

Authors:  Jacqueline Y Tyler; Xiao-Ming Xu; Ji-Xin Cheng
Journal:  Nanoscale       Date:  2013-08-14       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.